• -
74 Results
Embryo
Emerging Human Embryo Research Technologies, the 14-day Rule, and the Special Status of the Embryo
The authors examine a proposal for new human embryo and embryoid guidelines, writing that before conducting any research beyond day 14, scientists must develop clear, thoughtful and culturally sensitive guidelines that include limitations and oversight procedures to ensure that science responds to societal needs and values.
Kirstin R.W. Matthews, Ana S. Iltis, Sam Lowe December 21, 2021
Oil Refinery in Thailand
Gain foreign investment, gain U.S. security ties?
Reversing a more typical pattern of using existing security ties to attract investors, Guyana and Qatar have demonstrated how two small states can use foreign direct investment by oil and gas firms to bolster security ties with the U.S., writes energy fellow Jim Krane in a new article for Resources Policy.
Jim Krane December 3, 2021
Windmills in the sunset
More Transitions, Less Risk: How Renewable Energy Reduces Risks from Mining, Trade and Political Dependence
An emerging perspective in U.S. public discourse claims that a buildout of renewable electricity would exacerbate supply risks, mining intensity, and import dependence. This ScienceDirect article from fellow Jim Krane and graduate student Robert Idel contends the opposite is true, demonstrating how transitioning to renewables hugely reduces the materials, mining and political risk involved compared to coal.
Jim Krane September 9, 2021
Blue stem cell under microscope
Unproven Stem Cell Interventions: A Global Public Health Problem Requiring Global Deliberation
The unproven stem cell intervention industry is a worldwide, direct-to-consumer market where clinics offer stem cells or stem cell-derived components to patients with little to no scientific or clinical basis. In this paper, the authors call for the establishment of a World Health Organization Expert Advisory Committee on Regenerative Medicine to tackle this issue and provide guidance. Stem Cell Reports: https://doi.org/10.1016/j.stemcr.2021.05.004
Kirstin R.W. Matthews, Zubin Master, Mohamed Abou-el-Enein June 9, 2021
A stethoscope on American paper currency.
Development of Machine Learning Algorithms for the Prediction of Financial Toxicity in Localized Breast Cancer Following Surgical Treatment
The authors sought to develop and test a tool that accurately predicts the unique financial burden to individual patients undergoing treatment for breast cancer. JCO Clinical Cancer Informatics, an American Society of Clinical Oncology Journal
Anaeze C. Offodile II, Chris Sidey-Gibbons, André Pfob, Malke Assad, Stefanos Boukovalas, Yu-Li Lin, Jesse Creed Selber, Charles Butler March 26, 2021
A needle poking a human cell.
Rethinking Human Embryo Research Policies
It now seems technically feasible to culture human embryos beyond the “fourteen‐day limit,” which has the potential to increase scientific understanding of human development and perhaps improve infertility treatments. Robust stakeholder engagement preceded adoption of the fourteen‐day limit and should arguably be part of efforts to reassess it, write the authors.
Kirstin R.W. Matthews, Ana S. Iltis, Daniel S. Wagner, Nuria Gallego Marquez, Jason Scott Robert, Inmaculada de Melo-Martín, Marieke Bigg, Sarah Franklin, Soren Holm, Ingrid Metzler, Matteo A. Molè, Jochen Taupitz, Giuseppe Testa, Jeremy Sugarman February 26, 2021